Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yep... BVTK GOLD
HelpCom Inc. bought out by Bravatek Inc.
https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=250801353
https://sccefile.scc.virginia.gov/Business/0587631
STATE OF VIRGINIA (GOOD STANDING)
https://www.sec.gov/Archives/edgar/data/1449574/000147793217004631/bvtk_8k.htm
On September 20, 2017, Bravatek Solutions, Inc. (the “Company”) entered into a Letter of Intent with HelpComm, Inc. (“HelpComm”), a telecom construction services corporation located in Manassas, Virgina, to purchase HelpComm, pursuant to which HelpComm agreed to deal exclusively with the Company regarding an acquisition of HelpComm or its assets for 60 days, and the parties agreed to the following to the following non-binding preliminary acquisition terms, subject to due diligence of the parties and the negotiation and execution of a definitive purchase agreement acceptable to both parties:
The Company will acquire all outstanding capital stock of Helpcomm, and Helpcomm shall become a wholly owned subsidiary of the Company.
The Company will issue to the stockholders of Helpcomm 100,000 shares of a newly designated class of preferred stock, which preferred stock shall be non-voting prior to conversion into the Company’s common stock, and shall be convertible into 600,000,000 shares of common stock at the holder’s election so long as unissued, unreserved, and authorized common stock is available for issuance and such conversion will not result in the holder owning more than 4.99% of the issued and outstanding common stock at such time; and The Company will enter into employment agreements with two of the principals of Helpcomm, requiring the Company to compensate the principals with base salaries of $170,000 per year and $150,000 per year, with a performance bonus payable quarterly based on realized sales and actual expenses as compared to mutually agreed sales targets and budgeted expenses. The foregoing description of the agreement and its terms is qualified in its entirety by the full text of the agreement, which is filed as Exhibit 10.1 to, and incorporated by reference in, this report.
______________________________________________________________________
http://www.businessinsider.com/2018-iphone-rumors-apple-to-launch-3-new-iphones-including-low-cost-2017-11
APPLE ANNOUNCES THREE NEW IPHONES NOV. LAST YEAR
http://money.cnn.com/2018/01/29/technology/what-is-5g/index.html
http://bravatek.com/helpcomm-inc-receives-direct-vendor-status-from-the-nations-largest-consumer-wireless-carrier/
https://www.avclub.com/apple-to-release-3-new-iphones-including-its-biggest-e-1823354695
Thanks Hemp...
Updated the link here for everyone...
RXMD Overall Average:
96% BUY
Overall Average Signal calculated from all 13 indicators. Signal Strength is a long-term measurement of the historical strength of the Signal, while Signal Direction is a short-term (3-Day) measurement of the movement of the Signal.
https://www.barchart.com/stocks/quotes/RXMD/opinion
Wow... Thanks so much for this ONCI update Mary...
MODS Please sticky if possible...
CONVERSATION WITH ONCI CEO STEVE BERMAN 2/26/18
I managed to get in touch with ONCI CEO Steve Berman for a brief chat about some of the current questions that have come up of late. He was kind enough to take time out of his busy schedule (he was between meetings when we spoke) and shared as much info as he could in the time we had.
I want to preface this by saying that SB is a hardworking, passionate CEO who is working toward a goal of great success. This is the first time we've spoken at length and it made me realize that not only are we fortunate to have such a smart, savvy, articulate captain driving the ship, but we as shareholders (despite the countless hours of DD and gross assumptions we pour into ONCI), only the man and his team really know exactly what is happening behind the scenes. Hopefully some of what I report will clear things up.
PAST RELATIONSHIP WITH TXTM AND DRIVEALERTNOW
As we know, SB used to work for Protext Mobility (TXTM). Before Steve was on board, TXTM formed a licensing deal with DriveAlertNow to bring public awareness and a potential solution to the distracted driving epidemic. SB was then brought on board, as his years of marketing and sales experience seemed a natural fit to bring this 'solution' to the masses. However once SB began settling into his position, he came to realize that there were inherent problems, both with TXTM's dealings with DriveAlertNow and with the APP itself. The most complicated hurdle was that the software was programmed exclusively for android use, making it a very difficult sell. During this time, SB formed a relationship with Cogosense. and decided bringing them public through the ONCI shell made for a much better career opportunity. Three years ago he recognized the growing epidemic of distracted driving and wanted to be at the forefront in providing a solution. It was the right move given the immediate success he's found with Cogosense's products.
BIG AUTO
SB is still actively pursuing a deal with Big Auto. All previously discussed opportunities are still on the table and are being worked on. He said that working with such big corporate entities takes a great deal of time for various reasons, the biggest of which is the vetting of the technology. Each wants to see how this patented technology will best suit an integration into their own tech. Lofty requests have been made for changes, all of which are taking a lot of time and energy for Cogosense's programmers. BMW requested that the tech operate in 7 languages, for instance. This is no small feat. But it is being done. The opportunity is there and the timing is right to make something happen, and the ONCI team is doing everything they can to make it happen.
DEALERSHIPS
Sales to dealerships have been the immediate and most lucrative source of revenue for the company. SB saw this as his initial starting point for sales and has not let up for one moment. Not only have there been many 6 and 7-figure sales to dealerships, but he was quick to point out that retail sales have been VERY STRONG and that he is beginning to see increased orders and reorders. The dealerships LOVE the product, with many communicating details of the technology and its strong sales to their corporate HQ's. He's hopeful that their continued support will continue to bring further interest to Big Auto.
One thing he mentioned was that the managers of the some dealerships have complained about shareholder calls, some of which have been harassing in nature. This puts SB in a difficult spot, as he's trying to appease shareholders by being specific with names. However this is resulting in a strained relationship with SB and some of his clients. IMO--it's in our best interests as shareholders to keep our vetting to a professional level, if at all.
OTHER SALES
At this moment, ONCI has 37 independent sales reps with a clientele list suited for pitching our distracted driving technology to. This does NOT include any reps working for the (announced) distributors we hired: Capoli, US Warranty, Scully Lemoine, and Cataclean. These companies have units and literature and are currently 'pounding the pavement'. Of the 37 independent reps, ALL are commission based and YES, they are currently selling Bsafemobile to their accounts. The company is seeing many 'smaller' orders which SB noted are adding up. SB also noted that he's working with them toward an initial minimum goal of just 20 units per rep per month, which is a very plausible scenario. Think about it: that's over 8,000 units a year just in small orders. And this is a starting point.
SB also mentioned that there's a distributor in place with strong relationships with major retailers. He's very excited about this opportunity and sees this as a gateway to bring BsafeMobile to the mass market.
AMAZON
As we know there is a 3P seller on Amazon selling Bsafemobile. He is a former dealership employee who had a few units in his possession when he left his position. SB cannot list Bsafemobile as he will need to match this person’s pricing and cannot do that as he is vigilant in maintaining the integrity of the retail price in the marketplace. SB has purchased three units from this person himself and feels his supply is nearly exhausted. Once this person is out of stock, ONCI will begin selling on Amazon with an already-in-place promotional push from FLY.
LAW OFFICE
The Florida law office represents over 250 dealerships and has been actively taking orders for Bsafemobile. SB said the venture is a strong one and with continued support of the firm, monthly revenues will continue.
DENTAL
Currently exploring various non-dilutive funding opportunities to close on the acquisition, and begin rolling out the mobile-care business. He noted that most of the company's current income is being used to further develop the bread-winning Cogosense division of the business at this time.
MJ
Vetting companies as I write this. Issue is many businesses are not fully and properly licensed for all aspects of the business he is trying to establish.
T-TRADES & DILUTION
I asked specifically about dilution and he stated yet again to me that up until recently there has only been dilution to satisfy the LAM debt, which was reported on the annual. Since then, there has been VERY LITTLE dilution, which is being used solely for operating expenses, such as commission payments to the reps and legal fees.
As for T-trades, he said that in this instance we are seeing trades from a specific brokerage (I did not write it down and cannot recall which one it was) that are taking large buy orders from clients requesting a specific price. This large HUB brokerage then sends the order out to their smaller satellite or SPOKE brokerages that then record the buy and send back into the main ‘HUB’. The main HUB accumulates all the small orders from the smaller satellites and prints it as one large trade, or T-Trade at the end of the day. He assured me that despite all the crazy theories being touted, that he has nothing to do with the large T-Trades and that the dilution is minimal.
HEXAGON/DE/AUDIT
The $25,000 question. SB told me what he could and definitely cleared up any concerns I had. YES, the audit will happen. YES we will be Hexagon. YES DE debt will be cleared. Although the DE debt exists, it is MUCH LOWER than anyone knows or assumes it to be. SB feels that the former owners should be responsible for settling it and is legally pursuing this avenue. He said the total DE debt will be revealed on the 3/15 Q1 and again, will be MUCH lower than anyone thinks. But this is only ONE of the issues affecting the audit.
When MAZARS (He reiterated that it’s a 100% bona-fide a REAL letter) started the audit, there was the necessity of obtaining various legal documents from the former shell owners. All of which the owners are hesitating to provide due to the fact that they would accrue a variety of costs and expenses, including responsibility for the now infamous DE debt. Again, SB is legally pursuing this matter and will not let up until MAZARS is satisfied. Once the issues with the former owners and DE is fulfilled, MAZARS can complete the audit and ONCI can become HEXAGON.
That’s all we had time for but I think it clears up a good portion of what we are concerned about. On closing, despite the hours of DD I’ve put into researching ONCI, I was filled in on a LOT of info I did not know. Keep this in mind when others tout details they could not possibly know without being a part of the company.
SB is a very smart, aggressive Long Islander with an undying passion for building his business. At the end of the day, he’s the one you want running this company.
GLTA
Next stop 10+
Yep... Do it today folks...
Always, always, always set a high price when you post sell order on RXMD after you buy..!
My sell price is $2.88 for 2018.
In Reply to 'stockforce' on 'Progressive Care, Inc. (RXMD)
RXMD IS THE REAL GEM. This stock has been severely undervalued for years due to several reasons:
1. Progressive restructured its management team back in Jan. 2013 and got engaged in a 3(a)10 transaction for debt settlement in 2014, which helped them successfully pay off all the debt in Nov. 2015. They actually already had tremendous amount of revenues in those three years with double digit growth:
2013 net revenue: $9.33M
2014 net revenue: $11.27M
2015 net revenue: $13.64M
2. They completed their first audited financials of 2016 in April 2017. For the whole year of 2016, The stock price never surpassed 5 cents due to lack of audit and insufficient exposure to mass investors. See more DD of RXMD from INSTATRADER here:
https://investorshub.advfn.com/INSTATRADERS-LONG-TERM-OTC-WINNERS!!!!-32023/
3. The company started devoting more time and money on investors conferences and PR companies in 2017 after they made enormous achievements in their 2016 and 2017 revenue growth:
2015 net revenue: $13.64M
2016 net revenue: $18.32M
2017 net revenue: $20.1M
However, as the management said, institutional money would not start investing until they see at least 2 years of audits. The stock was still mostly unknown to mass investors at that time.
One of the biggest things the company is doing right now is to complete a second year audit of 2017. This is definitely a big GO for institutions and private equities, who normally have great investing interest in companies that have at least $20M revenue. The past week's price action was a clear indication to me that some institutional money started getting in with constant ask slaps and strong bid supports that were worth several million dollars.
Some other exciting things to expect this year, most likely within next several months are:
One or two M&A as a vehicle to help the company eventually uplist to NASDAQ. In CEO's own words from Uptick Newswire's interview on Feb 1, 2018:
Question - "Are you guys thinking about moving up to the NASDAQ?"
CEO, Shital Mars: "Yes. So the ultimate goal has always been to become fully SEC reporting and list on NASDAQ. We think that is the right place and right path for us to go. And we think healthcare is ripe for that change and we think there’s a lot of competition and opportunity in the marketplace for a company like ours to create something special and unique and worthy of being on NASDAQ. We also know that we want to have the right vehicle for it. So it’s not something we want to do just as we are today. We want to evolve into that NASDAQ worthy company, and we are putting all the staff in place, all the factors, all the personnel and resources in place right now to get us to there as our end goal."
Entry into CBD/Hemp Market
Acquiring additional 12 out-of-state licenses, which will make them obtain a total 29 state licenses in the U.S. by EOY.
The following are our strategic goals for 2018:
Achieve 25,000 prescriptions filled in a single month by December 2018
Increase annual overall sales to $22 million
Secure additional 340B contracts and long term care facility relationships
Further expansion into Palm Beach County
Achieve accreditation for non-sterile compounding
Achieve full enterprise profitability and earnings growth
Publish 2nd year of audited financial statements and leverage these statements to secure new investment opportunities for mergers and acquisitions
Opening more Pharmco Pharmacy Resource Centers in retirement and long term care communities.
Strengthening our tele-pharmacy platform
Closing Remarks
The strength of Progressive Care has always been in the hands of its employees and its shareholders. Without the loyalty and dedication of both, this Company would not be where it is today. We have thrived because of the unyielding support in the face of immense challenges and we know that we must never waver in our desire to always earn the trust that has been bestowed upon us. Thank you to all who believe in us and we look forward to delivering another phenomenal year.
Just for your fun reading, I have compiled a short version of Progressive's long history since its inception in 2006 and even before that all the way to 1997. This company is indeed a GEM that has just been noticed by BIG money. Get in now and we will witness how this stock will make its way all the way to NASDAQ.
A short version of ProgressiveCare's long history:
Everything started from a person called Buddy Young. He founded a publicly traded company called Web Star Training in 1997, engaging in the development, production, and distribution of training and educational video products and services. The company then changed its name to Advanced Knowledge, Inc. in 2000; and to Advanced Media, Inc. in 2003. Later, the company changed its name to Advanced Media Training, Inc. in 2004. Advanced Media Training is based in Encino, California. As of December 11, 2006, Advanced Media Training, Inc. was acquired by Dematco Corporation, a private UK company, in a reverse merger.
Progressive Training Inc. was incorporated by Mr. Young in Delaware on October 31, 2006. From the date it was incorporated until March 1, 2007, it was a wholly owned subsidiary of Dematco, Inc. On March 1, 2007, to facilitate Dematco's exit from the training business, Progressive Training acquired all of Dematco's assets and liabilities related to the production and distribution of workforce training videos.
In 2006, another person, Avraham A. Friedman, together with two partners, founded Pharmco in Florida. Mr. Friedman started in 1996 at the clerk level and after 4 years in 2000 became retail manager for a busy New York City independent pharmacy. He then left New York for Florida and started Pharmco in 2006.
Then, on October 21, 2010, Progressive Training, Inc. entered into an Agreement and Plan of Reverse Merger with Pharmco Corp. Upon the closing of the Exchange, Buddy Young resigned as the Company’s sole officer and director and David Leedy, Dennis Spiegelman and Mel Powell resigned from their positions as members of the Company’s board of directors. Simultaneously with the effectiveness of the Merger a new board of directors and new officers were appointed. The new board of directors consists of Avraham A. Friedman, Andy Subachan and Alan Jay Weisberg. Avraham A. Friedman was appointed as the Company’s Chief Executive Officer and President. Andy Subachan was appointed as the Company’s Chief Operating Officer. Alan Jay Weisberg was appointed as our Chief Financial Officer.
Mr. Weisberg is a Certified Public Accountant and currently operates Weisberg Brause & Co. Mr. Weisberg served as chief financial officer and as a director of QuickByte Software, Inc., from July 2008 to July 14, 2009. He served as chief financial officer and as a director of Getting Ready Corporation, Inc. from September 2007 through September 2008. From April 1998 through December 2006, Mr. Weisberg served as chief financial officer and as a director of Orthodontix, Inc. In addition, Mr. Weisberg served as chief financial officer and as a director of Protalix Biotehrapeutics, Inc. from December 2006 through April 2007. Mr. Weisberg also serves as a member of the board of directors and as secretary of Protech Global Holdings Corp. (“Protech”) Mr. Weisberg also previously served as chief financial officer of Protech.
On November 24, 2010, Progressive Training, Inc. (the “Company”) filed a Certificate of Ownership and Merger, pursuant to which its wholly-owned subsidiary, Progressive Care Inc. was merged into and with the Company (the “Merger”). In connection with the Merger, the Company changed its name to “Progressive Care Inc.”
Effective January 1, 2011, Mr. Young's another company, Futura Pictures, Inc. acquired from Progressive Training, Inc. all of its assets and liabilities related to Progressive’s workforce training business. On February 27, 2015, Mr. Young sold Futura Pictures to some South Korean guys and the company's name was changed to IMK Group, Inc.
On March 23, 2012, Progressive's CEO Avraham Friedman, issued his inaugural annual letter to the shareholders. The letter outlined Progressive Care's accomplishments in 2011 as well as its strategic goals and initiatives for 2012. Some highlights included hiring world renowned recording artist Luther Campbell as a company spokesperson. Mr. Campbell is deeply involved in the company's community outreach program and in the development of our anti-retroviral patient management program. Mr. Campbell's work will also be in combination with the new initiative planned by Progressive Care and PharmCo's HIV/AIDS Action Committee headed by Mrs. McDonald, a former Florida Department of Health Program Manager. They also have begun delivering with their fleet of visually branded delivery vehicles delivering to all of South Florida. The fleet is part of a marketing effort to enhance visibility of PharmCo in South Florida. They also signed an LOI to acquire an independent pharmacy in Coral Springs, FL.
On April 30, 2012, Progressive Care entered into the Equity Agreement with TCA. TCA committed to purchase up to $2,000,000 of the Company’s common stock for a period of twenty-four (24) months.
On August 30, 2012, Progressive Care announced that it has hired Mr. Vernon Watson as Chief Executive Officer and Ms. Shital Parikh Mars as Chief Operating Officer, effective August 27, 2012. Ms. Parikh was also appointed to the Board of Directors of Progressive Care at meeting held on August 24, 2012. Mr. Avraham Friedman, the Company’s former CEO, remained Chairman of the Board and assumed the role as the Company’s Chief Compliance Officer.
Mr. Watson was a Regional Sales Manager for MOMS Pharmacy in Melville, New York before joining Progressive. He helped increase the company’s sales and market share from New York to the tri-state area and Florida.
Ms. Parikh has been a vital consultant to the Company for the past three years (2009 - 2012). As President and CEO of Spark Financial Consulting, Ms. Parikh provided business development consulting services in which she advised the Company on human resources, financial reporting and transactions, operations, compliance, SEC filings, and investor relations, among other things. Ms. Parikh was also the Chief Operating Officer of Basis Financial, a boutique investment banking firm engaged by the Company. Her experience in the financial services industry centers on operational management, preparation and submission of financial statements, mergers & acquisitions, securities offerings, SEC reporting, due diligence, compliance, and regulatory audits. Ms. Parikh currently maintains 8 securities license registrations including the Series 7, Series 66, and Series 24.
On, January 17, 2013, Mr. Vernon Watson resigned from his position as the Chief Executive Officer of Progressive Care, Inc. after only five months with the company. His own words in the resignation letter: "Please accept this letter as my two-week notice of resignation. My last day of work will be Jan 25 th , 2013. It's been a wonderful 5 month experience working with Progressive Care. I have decided to relocate back to New York. I have enjoyed working with each and every one of you and appreciate the opportunities I've been given. I will do my best to hand off any current appointments prior to my last day of work. Please let me know if you need my help in any other way."
On January 21, 2013, Mr. Avraham Friedman resigned from his position as Chairman of the Board of Directors (the “Board”) of the Company. His own words in the resignation letter: "I thank each and every one of you for the opportunity to sit as Chairman of the Board. Regrettably, I must resign my position as Chairman of the Board effective immediately. I will, however, continue to retain my position as Chief Compliance Officer and look forward to working together to improve and grow Progressive Care. I thank you."
On January 22, 2013, the Board approved by unanimous written consent the appointment of Mr. Alan Jay Weisberg as the Company’s Interim Chief Executive Officer and Chairman of the Board. Mr. Weisberg has been a member of the Board and has served as Chief Financial Officer of the Company since October 2010.
On February 5, 2013, Mr. Avraham Friedman resigned from his position as Chief Compliance Officer of Progressive Care Inc. (the “Company”). In connection with Mr. Friedman’s resignation, the Company provided severance payment in the form of one half of Mr. Friedman’s current salary and one half of the premiums for Mr. Friedman’s insurance policy for a period of twenty-four weeks. His resignation letter:"This letter shall serve as notice that effective immediately, I hereby resign from my position as Chief Compliance Officer with Progressive Care, Inc. (the "Company", and all other positions to which I have been assigned, regardless of whether I served in such capacity, of the Company. The resignation is not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices. Sincerely."
On May 17, 2013, the board of directors of Progressive Care, Inc. dismissed Berman & Co., P.A., as the Company’s independent registered public accounting firm. On the same day, the board approved the engagement of Mallah Furman, Certified Public Accountants (“Mallah”), as the Company’s new independent registered public accounting firm.
On September 3, 2014, the Circuit Court of the Second Judicial Circuit for Leon County, Florida approved the 3(a)(10) transaction between Progressive Care and Tarpon Bay Partners. Progressive and Tarpon reasonably estimated that the fair market value of the Settlement Shares, the Fee Shares (as defined below) and all other amounts received or to be received by Tarpon is equal to approximately $2,434,673.00.
On March 18, 2015, Progressive terminated 12g with SEC.
On Dec 29, 2014, COO, Shital Mars released an open letter to Shareholders. Highlights of 2014:
Agreement and court approval to execute a 3(a)(10) transaction through Tarpon Bay Partners, LLC to eliminate $1.8 million in debt in the coming year
Filed unaudited financial statements with OTCMarkets through the most recent completed quarter
Restructured Management
Aggressively cut costs
Began a hiring program to recruit talent and meet growing demand
Renovated our PhamCo facility
Increased filled prescription counts by approx. 50% from 8,500 scripts per month to almost 13,000
Increased pharmacy sales by 35% to $8.1 million through September 30, 2014
The strategic goals for 2015:
Increase filled prescription counts to 20,000 per month by December 2015
Increase annual overall sales to $15 million
Achieve full enterprise profitability
Eliminate approximately $1.8 million in debt from the balance sheet
Merge, acquire or otherwise align ourselves with a synergistic independent pharmacy to create economies of scale
On November 10, 2015, Progressive announced the fourth consecutive quarters of profitability for PharmCo, LLC. Through the first nine months of 2015, PharmCo, LLC has recorded nearly $350,000 in net income. This is a significant turnaround when compared to net losses of $114,000 for PharmCo during the same time period in 2014. PharmCo has recorded profits in every quarter for the past 12 months. Profitability and positive cash flow in PharmCo has been achieved through concentrated marketing efforts, expansion of the compounded medication department and month over month of net increases in prescription sales. Progressive Care's consolidated income was nearly break even in the third quarter when adjusted for stock based compensation of $147,000.
Due to dramatic increases in demand, PharmCo initiated plans to expand the pharmacy this quarter. The facility currently fills approximately 50,000 prescriptions per quarter with minimal square footage devoted to compounding and long term care operations. The expansion plan would nearly double the amount of general filling space plus expand the compounding department. The company also is in the process of choosing and purchasing a robotic dispensing system. This system will allow PharmCo to tremendously increase production and save on labor cost. To take advantage of its marketing capabilities the company plans to expand to Palm Beach County. PharmCo expects the expansion to produce numerous positive results including improvements to efficiency and capacity as well as increased revenues.
Recently, PharmCo began the process of establishing 340B sales. Both PharmCo and its 340B provider are installing the vendor data necessary to start purchasing inventory for 340B patients. The Company anticipates that we will be realizing sales in this area before the end of the year. PharmCo is also quickly increasing its footprint in the Medication Therapy Management (MTM) industry. On a monthly basis, the company is seeing increases in the number of MTM cases provided by Medicare plans. While the company does not expect a material impact on this year's sales from MTM cases, MTM will be an important part of the business in 2016.
On December 10, 2015, Progressive announced that it has completed its 3(a)(10) transaction. In total the company has issued 282,275,000 shares of common stock to eliminate over $1.9 million in aged debt off of its balance sheet. The company estimates that of these shares approximately 12,000,000 shares will be returned to treasury.
As of December 9, 2015, total common stock issued and outstanding was 352,043,045 shares. This number is net of a 1,718,000 share adjustment as these shares are beneficially owned by the company through PharmCo, LLC. The total number of shares that are not beneficially owned by insiders or affiliates was 306,833,938.
On Dec 14, 2015, Progressive announced record November pharmacy revenues. The pharmacy filled approximately 15,000 prescriptions during the month of November, which is nearly a 30% increase over the same month last year. Historically, due to the open enrollment window, physicians undergo major changes to their patient base resulting decreases in prescriptions written. However, PharmCo grossed approximately $1.3 million in net revenues for the month despite the lower prescription count. The compounding department continues to drive strong revenue growth.
In the week of Jan. 4, 2016, Progressive will issue 2016 Open Letter to shareholders.
In October, 2017, Progressive uplisted to OTCQB.
In Jan 2018, Progressive announced over $20M NET REVENUE for 2017.
In Feb 2018, Progressive announced all-time-high single month revenue of $2.25M and 23,000 prescription fills.
To be continued...
$ $RXMD
200K more for me... Thank you..!
Get em while you can under .10...
$RXMD UPCOMING CATALYSTS / NEWS
Chicago Ventures Debt Payoff News: CV and any outstanding debt is most likely paid off now but waiting for confirmation. This will be HUGE news as all of their future financing will go traditional routes.
February Numbers: Week of March 12th or 19th - should be record revenues again with possibly our second 2M+ month.
Audited Annual Report: April 4th or sooner
Second year of audited fins: When we audit our second year of fins expect a nice bump. Having two years of audited fins is the gold standard for institutional monies to flow in. This will occur when we get our annual report.
March Numbers: Week of April 12th or 19th - should be record revenues again with possibly our third 2M+ month.
Additional technology partnerships / contracts: Progressive care is both a healthcare services and technology company. Expect additional PRs and contracts stating new revenues streams
Institutional buying: We've had what looks to be institutional buying recently and I would venture to guess we will receive more news about institutions covering us and major investments after we have our two years of audited financials in April.
Online Pharmacy / e-Commerce: With the news of Bitcoin and Amazon looking to get into the pharmacy space, expect additional news on RXMD about becoming a major online pharmacy.
CBD / MJ: Additional news about CBD and MJ will most likely be coming out in the next couple of months.
Conference call for shareholders: This occurs every quarter. Should happen around the release of the annual report if not sooner.
Tech / Tele-Pharm news: With the latest development of this being a tech play, we should hear more about their plan for tele-Pharmco and also we should hear from our NASDAQ independent board member on the latest developments.
Investor conferences to attract institutional investors: They will most likely PR these this month or next
New 340B contracts: Over the next month or two we will most likely hear about new 340B contracts from multiple partners
New Long term care facility relationships: The company continues to be active in the community with doctors, patients and long term facilities. Expect additional partnerships on this front.
Achieve accreditation for non-sterile compounding: One the company's stated goals for 2018 is receiving accreditation for non-sterile compounding. This will actually allow them to make more money with more of a backing.
Traditional financing: Expect news of traditional financing around spring/summer time frame.
Opening more Pharmco Pharmacy Resource Centers in retirement and long term care communities: Another 2018 goal of the company. They will announce more resource centers to again strengthen their relationships in the community.
More out of state licenses: They've already obtained 14 state licenses where they can do business and planning to expand to more states. We may hear more about these revenue streams as they add to the bottom line.
Purdue sales rep team: We should be hearing more about the Purdue pharma sales force to join the team for conducting out of state sales
Expansion / M&A: This is the blockbuster news we've been waiting for. This will come between now and June IMO.
RXMD broke 9...
Let's break that 10 this morning guys...
$RXMD UPCOMING CATALYSTS / NEWS
Chicago Ventures Debt Payoff News: CV and any outstanding debt is most likely paid off now but waiting for confirmation. This will be HUGE news as all of their future financing will go traditional routes.
February Numbers: Week of March 12th or 19th - should be record revenues again with possibly our second 2M+ month.
Audited Annual Report: April 4th or sooner
Second year of audited fins: When we audit our second year of fins expect a nice bump. Having two years of audited fins is the gold standard for institutional monies to flow in. This will occur when we get our annual report.
March Numbers: Week of April 12th or 19th - should be record revenues again with possibly our third 2M+ month.
Additional technology partnerships / contracts: Progressive care is both a healthcare services and technology company. Expect additional PRs and contracts stating new revenues streams
Institutional buying: We've had what looks to be institutional buying recently and I would venture to guess we will receive more news about institutions covering us and major investments after we have our two years of audited financials in April.
Online Pharmacy / e-Commerce: With the news of Bitcoin and Amazon looking to get into the pharmacy space, expect additional news on RXMD about becoming a major online pharmacy.
CBD / MJ: Additional news about CBD and MJ will most likely be coming out in the next couple of months.
Conference call for shareholders: This occurs every quarter. Should happen around the release of the annual report if not sooner.
Tech / Tele-Pharm news: With the latest development of this being a tech play, we should hear more about their plan for tele-Pharmco and also we should hear from our NASDAQ independent board member on the latest developments.
Investor conferences to attract institutional investors: They will most likely PR these this month or next
New 340B contracts: Over the next month or two we will most likely hear about new 340B contracts from multiple partners
New Long term care facility relationships: The company continues to be active in the community with doctors, patients and long term facilities. Expect additional partnerships on this front.
Achieve accreditation for non-sterile compounding: One the company's stated goals for 2018 is receiving accreditation for non-sterile compounding. This will actually allow them to make more money with more of a backing.
Traditional financing: Expect news of traditional financing around spring/summer time frame.
Opening more Pharmco Pharmacy Resource Centers in retirement and long term care communities: Another 2018 goal of the company. They will announce more resource centers to again strengthen their relationships in the community.
More out of state licenses: They've already obtained 14 state licenses where they can do business and planning to expand to more states. We may hear more about these revenue streams as they add to the bottom line.
Purdue sales rep team: We should be hearing more about the Purdue pharma sales force to join the team for conducting out of state sales
Expansion / M&A: This is the blockbuster news we've been waiting for. This will come between now and June IMO.
Right you are Badguy...
.10 is the magic breakout number. I wouldn't be surprised if savvy MMs are trying their damndest to keep this low so they can accumulate as much as under .10
I believe this to be accurate because over the past several trading days there seems to be that pesky V cut in the chart. Very strong evidence.
Watching ASCM and VERT usually tells me the story as to the shorting and accumulating. Usually is not a 100% guarantee.
They know once .10 breaks it'll be a cataclysmic explosion.
Don't be fooled by the MMs and hold your shares! I've seen this tactic many times before by those crafty bandits!
The Badguy
Thanks Idiots...
HBO is interested in DarkPulse because its a real, cutting edge multi million dollar company in the making.
Look at that chart $$$$$ no scam here!! Do you think 50 plus companies would be involved and just keeps growing!! $$$$!!!
With just HBO's coverage of Bravatek and DarkPulse alone (for their documentary series VICE) this could go right through the roof.
Seriously Folks, just think about this for a minute:
.."Invited by HBO to appear on Vice .. $BVTK CEO coming with"
https://twitter.com/DarkPulseTech/status/923576484450787330
(I believe taping begins mid march...)
Of all of the tech companies out there, Why DarkPulse and Bravatek?? VICE reports (documentary Style) on current relevant events. And of course, a 30 billion dollar media Juggernaut such as HBO/VICE is certainly capable of doing its own research as to determine the legitimacy of the companies it includes in its VICE documentaries (In this case, Bravatek and DarkPulse).
...So, lets summize why DarkPulse and Bravatek got invited to be on this particular episode in the first place...
I believe that HBO is interested in Bravatek/DarkPulse because they are real companies that posses relevant and legitimate cutting edge technologies that pertain (in real time) to many of the security threats that Governmental and corporate entities face in this day and age.
In other words, why else would HBO/VICE have Tom/Dennis and company on the show if it wasn't in regards to some major relevant technologies being implemented in real time?
I can tell you this, HBO did not get where it is today by wasting its time producing erroneous documentaries.
Time Warner as a whole is worth roughly $70 billion, and HBO accounts for $30 billion of that. (as of of 2015)
Yeppers... Gonna be a green week to 28 for BVTK is my projection...
HBO is interested in DarkPulse because its a real, cutting edge multi million dollar company in the making.
Look at that chart $$$$$ no scam here!! Do you think 50 plus companies would be involved and just keeps growing!! $$$$!!!
With just HBO's coverage of Bravatek and DarkPulse alone (for their documentary series VICE) this could go right through the roof.
Seriously Folks, just think about this for a minute:
.."Invited by HBO to appear on Vice .. $BVTK CEO coming with"
https://twitter.com/DarkPulseTech/status/923576484450787330
(I believe taping begins mid march...)
Of all of the tech companies out there, Why DarkPulse and Bravatek?? VICE reports (documentary Style) on current relevant events. And of course, a 30 billion dollar media Juggernaut such as HBO/VICE is certainly capable of doing its own research as to determine the legitimacy of the companies it includes in its VICE documentaries (In this case, Bravatek and DarkPulse).
...So, lets summize why DarkPulse and Bravatek got invited to be on this particular episode in the first place...
I believe that HBO is interested in Bravatek/DarkPulse because they are real companies that posses relevant and legitimate cutting edge technologies that pertain (in real time) to many of the security threats that Governmental and corporate entities face in this day and age.
In other words, why else would HBO/VICE have Tom/Dennis and company on the show if it wasn't in regards to some major relevant technologies being implemented in real time?
I can tell you this, HBO did not get where it is today by wasting its time producing erroneous documentaries.
Time Warner as a whole is worth roughly $70 billion, and HBO accounts for $30 billion of that. (as of of 2015)
Thanks PB...
Me thinks this Friday is gonna be BIG for OTTV..!
YUP! IT'S WAY TOO CHEAP NOW. EARNING SHOULD ANNOUNCE ON OR BEFORE FRIDAY.
Nice work Monte...
Always, always, always set a high price when you post sell order on RXMD after you buy..! My sell price is $2.88 for 2018.
In Reply to 'stockforce' on 'Progressive Care, Inc. (RXMD)
RXMD IS THE REAL GEM. This stock has been severely undervalued for years due to several reasons:
1. Progressive restructured its management team back in Jan. 2013 and got engaged in a 3(a)10 transaction for debt settlement in 2014, which helped them successfully pay off all the debt in Nov. 2015. They actually already had tremendous amount of revenues in those three years with double digit growth:
2013 net revenue: $9.33M
2014 net revenue: $11.27M
2015 net revenue: $13.64M
2. They completed their first audited financials of 2016 in April 2017. For the whole year of 2016, The stock price never surpassed 5 cents due to lack of audit and insufficient exposure to mass investors. See more DD of RXMD from INSTATRADER here:
https://investorshub.advfn.com/INSTATRADERS-LONG-TERM-OTC-WINNERS!!!!-32023/
3. The company started devoting more time and money on investors conferences and PR companies in 2017 after they made enormous achievements in their 2016 and 2017 revenue growth:
2015 net revenue: $13.64M
2016 net revenue: $18.32M
2017 net revenue: $20.1M
However, as the management said, institutional money would not start investing until they see at least 2 years of audits. The stock was still mostly unknown to mass investors at that time.
One of the biggest things the company is doing right now is to complete a second year audit of 2017. This is definitely a big GO for institutions and private equities, who normally have great investing interest in companies that have at least $20M revenue. The past week's price action was a clear indication to me that some institutional money started getting in with constant ask slaps and strong bid supports that were worth several million dollars.
Some other exciting things to expect this year, most likely within next several months are:
One or two M&A as a vehicle to help the company eventually uplist to NASDAQ. In CEO's own words from Uptick Newswire's interview on Feb 1, 2018:
Question - "Are you guys thinking about moving up to the NASDAQ?"
CEO, Shital Mars: "Yes. So the ultimate goal has always been to become fully SEC reporting and list on NASDAQ. We think that is the right place and right path for us to go. And we think healthcare is ripe for that change and we think there’s a lot of competition and opportunity in the marketplace for a company like ours to create something special and unique and worthy of being on NASDAQ. We also know that we want to have the right vehicle for it. So it’s not something we want to do just as we are today. We want to evolve into that NASDAQ worthy company, and we are putting all the staff in place, all the factors, all the personnel and resources in place right now to get us to there as our end goal."
Entry into CBD/Hemp Market
Acquiring additional 12 out-of-state licenses, which will make them obtain a total 29 state licenses in the U.S. by EOY.
The following are our strategic goals for 2018:
Achieve 25,000 prescriptions filled in a single month by December 2018
Increase annual overall sales to $22 million
Secure additional 340B contracts and long term care facility relationships
Further expansion into Palm Beach County
Achieve accreditation for non-sterile compounding
Achieve full enterprise profitability and earnings growth
Publish 2nd year of audited financial statements and leverage these statements to secure new investment opportunities for mergers and acquisitions
Opening more Pharmco Pharmacy Resource Centers in retirement and long term care communities.
Strengthening our tele-pharmacy platform
Closing Remarks
The strength of Progressive Care has always been in the hands of its employees and its shareholders. Without the loyalty and dedication of both, this Company would not be where it is today. We have thrived because of the unyielding support in the face of immense challenges and we know that we must never waver in our desire to always earn the trust that has been bestowed upon us. Thank you to all who believe in us and we look forward to delivering another phenomenal year.
Just for your fun reading, I have compiled a short version of Progressive's long history since its inception in 2006 and even before that all the way to 1997. This company is indeed a GEM that has just been noticed by BIG money. Get in now and we will witness how this stock will make its way all the way to NASDAQ.
A short version of ProgressiveCare's long history:
Everything started from a person called Buddy Young. He founded a publicly traded company called Web Star Training in 1997, engaging in the development, production, and distribution of training and educational video products and services. The company then changed its name to Advanced Knowledge, Inc. in 2000; and to Advanced Media, Inc. in 2003. Later, the company changed its name to Advanced Media Training, Inc. in 2004. Advanced Media Training is based in Encino, California. As of December 11, 2006, Advanced Media Training, Inc. was acquired by Dematco Corporation, a private UK company, in a reverse merger.
Progressive Training Inc. was incorporated by Mr. Young in Delaware on October 31, 2006. From the date it was incorporated until March 1, 2007, it was a wholly owned subsidiary of Dematco, Inc. On March 1, 2007, to facilitate Dematco's exit from the training business, Progressive Training acquired all of Dematco's assets and liabilities related to the production and distribution of workforce training videos.
In 2006, another person, Avraham A. Friedman, together with two partners, founded Pharmco in Florida. Mr. Friedman started in 1996 at the clerk level and after 4 years in 2000 became retail manager for a busy New York City independent pharmacy. He then left New York for Florida and started Pharmco in 2006.
Then, on October 21, 2010, Progressive Training, Inc. entered into an Agreement and Plan of Reverse Merger with Pharmco Corp. Upon the closing of the Exchange, Buddy Young resigned as the Company’s sole officer and director and David Leedy, Dennis Spiegelman and Mel Powell resigned from their positions as members of the Company’s board of directors. Simultaneously with the effectiveness of the Merger a new board of directors and new officers were appointed. The new board of directors consists of Avraham A. Friedman, Andy Subachan and Alan Jay Weisberg. Avraham A. Friedman was appointed as the Company’s Chief Executive Officer and President. Andy Subachan was appointed as the Company’s Chief Operating Officer. Alan Jay Weisberg was appointed as our Chief Financial Officer.
Mr. Weisberg is a Certified Public Accountant and currently operates Weisberg Brause & Co. Mr. Weisberg served as chief financial officer and as a director of QuickByte Software, Inc., from July 2008 to July 14, 2009. He served as chief financial officer and as a director of Getting Ready Corporation, Inc. from September 2007 through September 2008. From April 1998 through December 2006, Mr. Weisberg served as chief financial officer and as a director of Orthodontix, Inc. In addition, Mr. Weisberg served as chief financial officer and as a director of Protalix Biotehrapeutics, Inc. from December 2006 through April 2007. Mr. Weisberg also serves as a member of the board of directors and as secretary of Protech Global Holdings Corp. (“Protech”) Mr. Weisberg also previously served as chief financial officer of Protech.
On November 24, 2010, Progressive Training, Inc. (the “Company”) filed a Certificate of Ownership and Merger, pursuant to which its wholly-owned subsidiary, Progressive Care Inc. was merged into and with the Company (the “Merger”). In connection with the Merger, the Company changed its name to “Progressive Care Inc.”
Effective January 1, 2011, Mr. Young's another company, Futura Pictures, Inc. acquired from Progressive Training, Inc. all of its assets and liabilities related to Progressive’s workforce training business. On February 27, 2015, Mr. Young sold Futura Pictures to some South Korean guys and the company's name was changed to IMK Group, Inc.
On March 23, 2012, Progressive's CEO Avraham Friedman, issued his inaugural annual letter to the shareholders. The letter outlined Progressive Care's accomplishments in 2011 as well as its strategic goals and initiatives for 2012. Some highlights included hiring world renowned recording artist Luther Campbell as a company spokesperson. Mr. Campbell is deeply involved in the company's community outreach program and in the development of our anti-retroviral patient management program. Mr. Campbell's work will also be in combination with the new initiative planned by Progressive Care and PharmCo's HIV/AIDS Action Committee headed by Mrs. McDonald, a former Florida Department of Health Program Manager. They also have begun delivering with their fleet of visually branded delivery vehicles delivering to all of South Florida. The fleet is part of a marketing effort to enhance visibility of PharmCo in South Florida. They also signed an LOI to acquire an independent pharmacy in Coral Springs, FL.
On April 30, 2012, Progressive Care entered into the Equity Agreement with TCA. TCA committed to purchase up to $2,000,000 of the Company’s common stock for a period of twenty-four (24) months.
On August 30, 2012, Progressive Care announced that it has hired Mr. Vernon Watson as Chief Executive Officer and Ms. Shital Parikh Mars as Chief Operating Officer, effective August 27, 2012. Ms. Parikh was also appointed to the Board of Directors of Progressive Care at meeting held on August 24, 2012. Mr. Avraham Friedman, the Company’s former CEO, remained Chairman of the Board and assumed the role as the Company’s Chief Compliance Officer.
Mr. Watson was a Regional Sales Manager for MOMS Pharmacy in Melville, New York before joining Progressive. He helped increase the company’s sales and market share from New York to the tri-state area and Florida.
Ms. Parikh has been a vital consultant to the Company for the past three years (2009 - 2012). As President and CEO of Spark Financial Consulting, Ms. Parikh provided business development consulting services in which she advised the Company on human resources, financial reporting and transactions, operations, compliance, SEC filings, and investor relations, among other things. Ms. Parikh was also the Chief Operating Officer of Basis Financial, a boutique investment banking firm engaged by the Company. Her experience in the financial services industry centers on operational management, preparation and submission of financial statements, mergers & acquisitions, securities offerings, SEC reporting, due diligence, compliance, and regulatory audits. Ms. Parikh currently maintains 8 securities license registrations including the Series 7, Series 66, and Series 24.
On, January 17, 2013, Mr. Vernon Watson resigned from his position as the Chief Executive Officer of Progressive Care, Inc. after only five months with the company. His own words in the resignation letter: "Please accept this letter as my two-week notice of resignation. My last day of work will be Jan 25 th , 2013. It's been a wonderful 5 month experience working with Progressive Care. I have decided to relocate back to New York. I have enjoyed working with each and every one of you and appreciate the opportunities I've been given. I will do my best to hand off any current appointments prior to my last day of work. Please let me know if you need my help in any other way."
On January 21, 2013, Mr. Avraham Friedman resigned from his position as Chairman of the Board of Directors (the “Board”) of the Company. His own words in the resignation letter: "I thank each and every one of you for the opportunity to sit as Chairman of the Board. Regrettably, I must resign my position as Chairman of the Board effective immediately. I will, however, continue to retain my position as Chief Compliance Officer and look forward to working together to improve and grow Progressive Care. I thank you."
On January 22, 2013, the Board approved by unanimous written consent the appointment of Mr. Alan Jay Weisberg as the Company’s Interim Chief Executive Officer and Chairman of the Board. Mr. Weisberg has been a member of the Board and has served as Chief Financial Officer of the Company since October 2010.
On February 5, 2013, Mr. Avraham Friedman resigned from his position as Chief Compliance Officer of Progressive Care Inc. (the “Company”). In connection with Mr. Friedman’s resignation, the Company provided severance payment in the form of one half of Mr. Friedman’s current salary and one half of the premiums for Mr. Friedman’s insurance policy for a period of twenty-four weeks. His resignation letter:"This letter shall serve as notice that effective immediately, I hereby resign from my position as Chief Compliance Officer with Progressive Care, Inc. (the "Company", and all other positions to which I have been assigned, regardless of whether I served in such capacity, of the Company. The resignation is not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices. Sincerely."
On May 17, 2013, the board of directors of Progressive Care, Inc. dismissed Berman & Co., P.A., as the Company’s independent registered public accounting firm. On the same day, the board approved the engagement of Mallah Furman, Certified Public Accountants (“Mallah”), as the Company’s new independent registered public accounting firm.
On September 3, 2014, the Circuit Court of the Second Judicial Circuit for Leon County, Florida approved the 3(a)(10) transaction between Progressive Care and Tarpon Bay Partners. Progressive and Tarpon reasonably estimated that the fair market value of the Settlement Shares, the Fee Shares (as defined below) and all other amounts received or to be received by Tarpon is equal to approximately $2,434,673.00.
On March 18, 2015, Progressive terminated 12g with SEC.
On Dec 29, 2014, COO, Shital Mars released an open letter to Shareholders. Highlights of 2014:
Agreement and court approval to execute a 3(a)(10) transaction through Tarpon Bay Partners, LLC to eliminate $1.8 million in debt in the coming year
Filed unaudited financial statements with OTCMarkets through the most recent completed quarter
Restructured Management
Aggressively cut costs
Began a hiring program to recruit talent and meet growing demand
Renovated our PhamCo facility
Increased filled prescription counts by approx. 50% from 8,500 scripts per month to almost 13,000
Increased pharmacy sales by 35% to $8.1 million through September 30, 2014
The strategic goals for 2015:
Increase filled prescription counts to 20,000 per month by December 2015
Increase annual overall sales to $15 million
Achieve full enterprise profitability
Eliminate approximately $1.8 million in debt from the balance sheet
Merge, acquire or otherwise align ourselves with a synergistic independent pharmacy to create economies of scale
On November 10, 2015, Progressive announced the fourth consecutive quarters of profitability for PharmCo, LLC. Through the first nine months of 2015, PharmCo, LLC has recorded nearly $350,000 in net income. This is a significant turnaround when compared to net losses of $114,000 for PharmCo during the same time period in 2014. PharmCo has recorded profits in every quarter for the past 12 months. Profitability and positive cash flow in PharmCo has been achieved through concentrated marketing efforts, expansion of the compounded medication department and month over month of net increases in prescription sales. Progressive Care's consolidated income was nearly break even in the third quarter when adjusted for stock based compensation of $147,000.
Due to dramatic increases in demand, PharmCo initiated plans to expand the pharmacy this quarter. The facility currently fills approximately 50,000 prescriptions per quarter with minimal square footage devoted to compounding and long term care operations. The expansion plan would nearly double the amount of general filling space plus expand the compounding department. The company also is in the process of choosing and purchasing a robotic dispensing system. This system will allow PharmCo to tremendously increase production and save on labor cost. To take advantage of its marketing capabilities the company plans to expand to Palm Beach County. PharmCo expects the expansion to produce numerous positive results including improvements to efficiency and capacity as well as increased revenues.
Recently, PharmCo began the process of establishing 340B sales. Both PharmCo and its 340B provider are installing the vendor data necessary to start purchasing inventory for 340B patients. The Company anticipates that we will be realizing sales in this area before the end of the year. PharmCo is also quickly increasing its footprint in the Medication Therapy Management (MTM) industry. On a monthly basis, the company is seeing increases in the number of MTM cases provided by Medicare plans. While the company does not expect a material impact on this year's sales from MTM cases, MTM will be an important part of the business in 2016.
On December 10, 2015, Progressive announced that it has completed its 3(a)(10) transaction. In total the company has issued 282,275,000 shares of common stock to eliminate over $1.9 million in aged debt off of its balance sheet. The company estimates that of these shares approximately 12,000,000 shares will be returned to treasury.
As of December 9, 2015, total common stock issued and outstanding was 352,043,045 shares. This number is net of a 1,718,000 share adjustment as these shares are beneficially owned by the company through PharmCo, LLC. The total number of shares that are not beneficially owned by insiders or affiliates was 306,833,938.
On Dec 14, 2015, Progressive announced record November pharmacy revenues. The pharmacy filled approximately 15,000 prescriptions during the month of November, which is nearly a 30% increase over the same month last year. Historically, due to the open enrollment window, physicians undergo major changes to their patient base resulting decreases in prescriptions written. However, PharmCo grossed approximately $1.3 million in net revenues for the month despite the lower prescription count. The compounding department continues to drive strong revenue growth.
In the week of Jan. 4, 2016, Progressive will issue 2016 Open Letter to shareholders.
In October, 2017, Progressive uplisted to OTCQB.
In Jan 2018, Progressive announced over $20M NET REVENUE for 2017.
In Feb 2018, Progressive announced all-time-high single month revenue of $2.25M and 23,000 prescription fills.
To be continued...
$ $RXMD
Yep... Do it today folks...
Let's get this back to .09+ guys...
Always, always, always set a high price when you post sell order on RXMD after you buy..!
My sell price is $2.88 for 2018.
In Reply to 'stockforce' on 'Progressive Care, Inc. (RXMD)
RXMD IS THE REAL GEM. This stock has been severely undervalued for years due to several reasons:
1. Progressive restructured its management team back in Jan. 2013 and got engaged in a 3(a)10 transaction for debt settlement in 2014, which helped them successfully pay off all the debt in Nov. 2015. They actually already had tremendous amount of revenues in those three years with double digit growth:
2013 net revenue: $9.33M
2014 net revenue: $11.27M
2015 net revenue: $13.64M
2. They completed their first audited financials of 2016 in April 2017. For the whole year of 2016, The stock price never surpassed 5 cents due to lack of audit and insufficient exposure to mass investors. See more DD of RXMD from INSTATRADER here:
https://investorshub.advfn.com/INSTATRADERS-LONG-TERM-OTC-WINNERS!!!!-32023/
3. The company started devoting more time and money on investors conferences and PR companies in 2017 after they made enormous achievements in their 2016 and 2017 revenue growth:
2015 net revenue: $13.64M
2016 net revenue: $18.32M
2017 net revenue: $20.1M
However, as the management said, institutional money would not start investing until they see at least 2 years of audits. The stock was still mostly unknown to mass investors at that time.
One of the biggest things the company is doing right now is to complete a second year audit of 2017. This is definitely a big GO for institutions and private equities, who normally have great investing interest in companies that have at least $20M revenue. The past week's price action was a clear indication to me that some institutional money started getting in with constant ask slaps and strong bid supports that were worth several million dollars.
Some other exciting things to expect this year, most likely within next several months are:
One or two M&A as a vehicle to help the company eventually uplist to NASDAQ. In CEO's own words from Uptick Newswire's interview on Feb 1, 2018:
Question - "Are you guys thinking about moving up to the NASDAQ?"
CEO, Shital Mars: "Yes. So the ultimate goal has always been to become fully SEC reporting and list on NASDAQ. We think that is the right place and right path for us to go. And we think healthcare is ripe for that change and we think there’s a lot of competition and opportunity in the marketplace for a company like ours to create something special and unique and worthy of being on NASDAQ. We also know that we want to have the right vehicle for it. So it’s not something we want to do just as we are today. We want to evolve into that NASDAQ worthy company, and we are putting all the staff in place, all the factors, all the personnel and resources in place right now to get us to there as our end goal."
Entry into CBD/Hemp Market
Acquiring additional 12 out-of-state licenses, which will make them obtain a total 29 state licenses in the U.S. by EOY.
The following are our strategic goals for 2018:
Achieve 25,000 prescriptions filled in a single month by December 2018
Increase annual overall sales to $22 million
Secure additional 340B contracts and long term care facility relationships
Further expansion into Palm Beach County
Achieve accreditation for non-sterile compounding
Achieve full enterprise profitability and earnings growth
Publish 2nd year of audited financial statements and leverage these statements to secure new investment opportunities for mergers and acquisitions
Opening more Pharmco Pharmacy Resource Centers in retirement and long term care communities.
Strengthening our tele-pharmacy platform
Closing Remarks
The strength of Progressive Care has always been in the hands of its employees and its shareholders. Without the loyalty and dedication of both, this Company would not be where it is today. We have thrived because of the unyielding support in the face of immense challenges and we know that we must never waver in our desire to always earn the trust that has been bestowed upon us. Thank you to all who believe in us and we look forward to delivering another phenomenal year.
Just for your fun reading, I have compiled a short version of Progressive's long history since its inception in 2006 and even before that all the way to 1997. This company is indeed a GEM that has just been noticed by BIG money. Get in now and we will witness how this stock will make its way all the way to NASDAQ.
A short version of ProgressiveCare's long history:
Everything started from a person called Buddy Young. He founded a publicly traded company called Web Star Training in 1997, engaging in the development, production, and distribution of training and educational video products and services. The company then changed its name to Advanced Knowledge, Inc. in 2000; and to Advanced Media, Inc. in 2003. Later, the company changed its name to Advanced Media Training, Inc. in 2004. Advanced Media Training is based in Encino, California. As of December 11, 2006, Advanced Media Training, Inc. was acquired by Dematco Corporation, a private UK company, in a reverse merger.
Progressive Training Inc. was incorporated by Mr. Young in Delaware on October 31, 2006. From the date it was incorporated until March 1, 2007, it was a wholly owned subsidiary of Dematco, Inc. On March 1, 2007, to facilitate Dematco's exit from the training business, Progressive Training acquired all of Dematco's assets and liabilities related to the production and distribution of workforce training videos.
In 2006, another person, Avraham A. Friedman, together with two partners, founded Pharmco in Florida. Mr. Friedman started in 1996 at the clerk level and after 4 years in 2000 became retail manager for a busy New York City independent pharmacy. He then left New York for Florida and started Pharmco in 2006.
Then, on October 21, 2010, Progressive Training, Inc. entered into an Agreement and Plan of Reverse Merger with Pharmco Corp. Upon the closing of the Exchange, Buddy Young resigned as the Company’s sole officer and director and David Leedy, Dennis Spiegelman and Mel Powell resigned from their positions as members of the Company’s board of directors. Simultaneously with the effectiveness of the Merger a new board of directors and new officers were appointed. The new board of directors consists of Avraham A. Friedman, Andy Subachan and Alan Jay Weisberg. Avraham A. Friedman was appointed as the Company’s Chief Executive Officer and President. Andy Subachan was appointed as the Company’s Chief Operating Officer. Alan Jay Weisberg was appointed as our Chief Financial Officer.
Mr. Weisberg is a Certified Public Accountant and currently operates Weisberg Brause & Co. Mr. Weisberg served as chief financial officer and as a director of QuickByte Software, Inc., from July 2008 to July 14, 2009. He served as chief financial officer and as a director of Getting Ready Corporation, Inc. from September 2007 through September 2008. From April 1998 through December 2006, Mr. Weisberg served as chief financial officer and as a director of Orthodontix, Inc. In addition, Mr. Weisberg served as chief financial officer and as a director of Protalix Biotehrapeutics, Inc. from December 2006 through April 2007. Mr. Weisberg also serves as a member of the board of directors and as secretary of Protech Global Holdings Corp. (“Protech”) Mr. Weisberg also previously served as chief financial officer of Protech.
On November 24, 2010, Progressive Training, Inc. (the “Company”) filed a Certificate of Ownership and Merger, pursuant to which its wholly-owned subsidiary, Progressive Care Inc. was merged into and with the Company (the “Merger”). In connection with the Merger, the Company changed its name to “Progressive Care Inc.”
Effective January 1, 2011, Mr. Young's another company, Futura Pictures, Inc. acquired from Progressive Training, Inc. all of its assets and liabilities related to Progressive’s workforce training business. On February 27, 2015, Mr. Young sold Futura Pictures to some South Korean guys and the company's name was changed to IMK Group, Inc.
On March 23, 2012, Progressive's CEO Avraham Friedman, issued his inaugural annual letter to the shareholders. The letter outlined Progressive Care's accomplishments in 2011 as well as its strategic goals and initiatives for 2012. Some highlights included hiring world renowned recording artist Luther Campbell as a company spokesperson. Mr. Campbell is deeply involved in the company's community outreach program and in the development of our anti-retroviral patient management program. Mr. Campbell's work will also be in combination with the new initiative planned by Progressive Care and PharmCo's HIV/AIDS Action Committee headed by Mrs. McDonald, a former Florida Department of Health Program Manager. They also have begun delivering with their fleet of visually branded delivery vehicles delivering to all of South Florida. The fleet is part of a marketing effort to enhance visibility of PharmCo in South Florida. They also signed an LOI to acquire an independent pharmacy in Coral Springs, FL.
On April 30, 2012, Progressive Care entered into the Equity Agreement with TCA. TCA committed to purchase up to $2,000,000 of the Company’s common stock for a period of twenty-four (24) months.
On August 30, 2012, Progressive Care announced that it has hired Mr. Vernon Watson as Chief Executive Officer and Ms. Shital Parikh Mars as Chief Operating Officer, effective August 27, 2012. Ms. Parikh was also appointed to the Board of Directors of Progressive Care at meeting held on August 24, 2012. Mr. Avraham Friedman, the Company’s former CEO, remained Chairman of the Board and assumed the role as the Company’s Chief Compliance Officer.
Mr. Watson was a Regional Sales Manager for MOMS Pharmacy in Melville, New York before joining Progressive. He helped increase the company’s sales and market share from New York to the tri-state area and Florida.
Ms. Parikh has been a vital consultant to the Company for the past three years (2009 - 2012). As President and CEO of Spark Financial Consulting, Ms. Parikh provided business development consulting services in which she advised the Company on human resources, financial reporting and transactions, operations, compliance, SEC filings, and investor relations, among other things. Ms. Parikh was also the Chief Operating Officer of Basis Financial, a boutique investment banking firm engaged by the Company. Her experience in the financial services industry centers on operational management, preparation and submission of financial statements, mergers & acquisitions, securities offerings, SEC reporting, due diligence, compliance, and regulatory audits. Ms. Parikh currently maintains 8 securities license registrations including the Series 7, Series 66, and Series 24.
On, January 17, 2013, Mr. Vernon Watson resigned from his position as the Chief Executive Officer of Progressive Care, Inc. after only five months with the company. His own words in the resignation letter: "Please accept this letter as my two-week notice of resignation. My last day of work will be Jan 25 th , 2013. It's been a wonderful 5 month experience working with Progressive Care. I have decided to relocate back to New York. I have enjoyed working with each and every one of you and appreciate the opportunities I've been given. I will do my best to hand off any current appointments prior to my last day of work. Please let me know if you need my help in any other way."
On January 21, 2013, Mr. Avraham Friedman resigned from his position as Chairman of the Board of Directors (the “Board”) of the Company. His own words in the resignation letter: "I thank each and every one of you for the opportunity to sit as Chairman of the Board. Regrettably, I must resign my position as Chairman of the Board effective immediately. I will, however, continue to retain my position as Chief Compliance Officer and look forward to working together to improve and grow Progressive Care. I thank you."
On January 22, 2013, the Board approved by unanimous written consent the appointment of Mr. Alan Jay Weisberg as the Company’s Interim Chief Executive Officer and Chairman of the Board. Mr. Weisberg has been a member of the Board and has served as Chief Financial Officer of the Company since October 2010.
On February 5, 2013, Mr. Avraham Friedman resigned from his position as Chief Compliance Officer of Progressive Care Inc. (the “Company”). In connection with Mr. Friedman’s resignation, the Company provided severance payment in the form of one half of Mr. Friedman’s current salary and one half of the premiums for Mr. Friedman’s insurance policy for a period of twenty-four weeks. His resignation letter:"This letter shall serve as notice that effective immediately, I hereby resign from my position as Chief Compliance Officer with Progressive Care, Inc. (the "Company", and all other positions to which I have been assigned, regardless of whether I served in such capacity, of the Company. The resignation is not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices. Sincerely."
On May 17, 2013, the board of directors of Progressive Care, Inc. dismissed Berman & Co., P.A., as the Company’s independent registered public accounting firm. On the same day, the board approved the engagement of Mallah Furman, Certified Public Accountants (“Mallah”), as the Company’s new independent registered public accounting firm.
On September 3, 2014, the Circuit Court of the Second Judicial Circuit for Leon County, Florida approved the 3(a)(10) transaction between Progressive Care and Tarpon Bay Partners. Progressive and Tarpon reasonably estimated that the fair market value of the Settlement Shares, the Fee Shares (as defined below) and all other amounts received or to be received by Tarpon is equal to approximately $2,434,673.00.
On March 18, 2015, Progressive terminated 12g with SEC.
On Dec 29, 2014, COO, Shital Mars released an open letter to Shareholders. Highlights of 2014:
Agreement and court approval to execute a 3(a)(10) transaction through Tarpon Bay Partners, LLC to eliminate $1.8 million in debt in the coming year
Filed unaudited financial statements with OTCMarkets through the most recent completed quarter
Restructured Management
Aggressively cut costs
Began a hiring program to recruit talent and meet growing demand
Renovated our PhamCo facility
Increased filled prescription counts by approx. 50% from 8,500 scripts per month to almost 13,000
Increased pharmacy sales by 35% to $8.1 million through September 30, 2014
The strategic goals for 2015:
Increase filled prescription counts to 20,000 per month by December 2015
Increase annual overall sales to $15 million
Achieve full enterprise profitability
Eliminate approximately $1.8 million in debt from the balance sheet
Merge, acquire or otherwise align ourselves with a synergistic independent pharmacy to create economies of scale
On November 10, 2015, Progressive announced the fourth consecutive quarters of profitability for PharmCo, LLC. Through the first nine months of 2015, PharmCo, LLC has recorded nearly $350,000 in net income. This is a significant turnaround when compared to net losses of $114,000 for PharmCo during the same time period in 2014. PharmCo has recorded profits in every quarter for the past 12 months. Profitability and positive cash flow in PharmCo has been achieved through concentrated marketing efforts, expansion of the compounded medication department and month over month of net increases in prescription sales. Progressive Care's consolidated income was nearly break even in the third quarter when adjusted for stock based compensation of $147,000.
Due to dramatic increases in demand, PharmCo initiated plans to expand the pharmacy this quarter. The facility currently fills approximately 50,000 prescriptions per quarter with minimal square footage devoted to compounding and long term care operations. The expansion plan would nearly double the amount of general filling space plus expand the compounding department. The company also is in the process of choosing and purchasing a robotic dispensing system. This system will allow PharmCo to tremendously increase production and save on labor cost. To take advantage of its marketing capabilities the company plans to expand to Palm Beach County. PharmCo expects the expansion to produce numerous positive results including improvements to efficiency and capacity as well as increased revenues.
Recently, PharmCo began the process of establishing 340B sales. Both PharmCo and its 340B provider are installing the vendor data necessary to start purchasing inventory for 340B patients. The Company anticipates that we will be realizing sales in this area before the end of the year. PharmCo is also quickly increasing its footprint in the Medication Therapy Management (MTM) industry. On a monthly basis, the company is seeing increases in the number of MTM cases provided by Medicare plans. While the company does not expect a material impact on this year's sales from MTM cases, MTM will be an important part of the business in 2016.
On December 10, 2015, Progressive announced that it has completed its 3(a)(10) transaction. In total the company has issued 282,275,000 shares of common stock to eliminate over $1.9 million in aged debt off of its balance sheet. The company estimates that of these shares approximately 12,000,000 shares will be returned to treasury.
As of December 9, 2015, total common stock issued and outstanding was 352,043,045 shares. This number is net of a 1,718,000 share adjustment as these shares are beneficially owned by the company through PharmCo, LLC. The total number of shares that are not beneficially owned by insiders or affiliates was 306,833,938.
On Dec 14, 2015, Progressive announced record November pharmacy revenues. The pharmacy filled approximately 15,000 prescriptions during the month of November, which is nearly a 30% increase over the same month last year. Historically, due to the open enrollment window, physicians undergo major changes to their patient base resulting decreases in prescriptions written. However, PharmCo grossed approximately $1.3 million in net revenues for the month despite the lower prescription count. The compounding department continues to drive strong revenue growth.
In the week of Jan. 4, 2016, Progressive will issue 2016 Open Letter to shareholders.
In October, 2017, Progressive uplisted to OTCQB.
In Jan 2018, Progressive announced over $20M NET REVENUE for 2017.
In Feb 2018, Progressive announced all-time-high single month revenue of $2.25M and 23,000 prescription fills.
To be continued...
$$$RXMD
Yep...
Breaking 10 by eod...
I believe there is institutional buying based off of the MMs on bid. There are certain MMs that are institutional based that have never showed up for RXMD before.
Yeppers...
Further developed, tested and successfully integrated.
BVTK's Ecrypt One passed all integration tests for NATO business partner...Proud of our technicals folks...Significant opportunity
Ecrypt One passed all integration tests for NATO business partner...Proud of our technical folks...Significant opportunity
— Bravatek Solutions (@bravatek) January 30, 2018
BVTK negotiating Ecrypt One deal for use by large company's employees in 390 large buildings on the West Coast (USA). "The word is out about Ecrypt One's utility and robustness" says BVTK's CEO. All the T&E (Test & Evaluation) took extra time--but was well worth it!
— Bravatek Solutions (@bravatek) November 22, 2017
Why are so so unhappy with your investment in ONCI...
Up some 20% today... Things will get bettah...
Be happy my friend...
Yeppers...
Just the start of green ginormous...
$ONCI Marketing Team expansion soon #bsafemobile will be everywhere!
#REVENUESRULE #GOINGWAYUP #GLAD2BELOADEDUP
https://ih.advfn.com/p.php?pid=nmona&article=76633594
Thank you kindly Dr PennyStock...
Looking forward to this week...
Thanks so much Doc...
So you're saying that it may break .10 but then pullback to 7 or 8..?
You have previously mentions that:
RXMD will run to .10 - .15, or even maybe .20.
But possibly take a few more weeks to do so..?
In Reply to 'Dr PennyStock' on 'Progressive Care, Inc. (RXMD)'
It may pullback to touch again the trendline, to cool down the indicators, and, gain momentum to break .1, or break .1, and, only then make a pullback to test that same .1 as support. Anyway, in any of the above case scenarios, .1 will be broken, if not next week, the one after.
Like I said on my analysis before, RXMD will run to .10 - .15, or even maybe .20.
Anybody care to make an approx projection of RXMD pps in the coming week or so..?
[My educated guess is we break .12 by close on Friday]
Anybody care to make an approx projection of RXMD pps in the coming week or so..?
Doctor Penny...
Care to make an approx projection of RXMD pps in the coming week or so..?
Much appreciated my friend...
YEPPERS...
RXMD IS THE REAL GEM. This stock has been severely undervalued for years due to several reasons:
1. Progressive restructured its management team back in Jan. 2013 and got engaged in a 3(a)10 transaction for debt settlement in 2014, which helped them successfully pay off all the debt in Nov. 2015. They actually already had tremendous amount of revenues in those three years with double digit growth:
2013 net revenue: $9.33M
2014 net revenue: $11.27M
2015 net revenue: $13.64M
2. They completed their first audited financials of 2016 in April 2017. For the whole year of 2016, The stock price never surpassed 5 cents due to lack of audit and insufficient exposure to mass investors. See more DD of RXMD from INSTATRADER here:
https://investorshub.advfn.com/INSTATRADERS-LONG-TERM-OTC-WINNERS!!!!-32023/
3. The company started devoting more time and money on investors conferences and PR companies in 2017 after they made enormous achievements in their 2016 and 2017 revenue growth:
2015 net revenue: $13.64M
2016 net revenue: $18.32M
2017 net revenue: $20.1M
However, as the management said, institutional money would not start investing until they see at least 2 years of audits. The stock was still mostly unknown to mass investors at that time.
One of the biggest things the company is doing right now is to complete a second year audit of 2017. This is definitely a big GO for institutions and private equities, who normally have great investing interest in companies that have at least $20M revenue. The past week's price action was a clear indication to me that some institutional money started getting in with constant ask slaps and strong bid supports that were worth several million dollars.
Some other exciting things to expect this year, most likely within next several months are:
One or two M&A as a vehicle to help the company eventually uplist to NASDAQ. In CEO's own words from Uptick Newswire's interview on Feb 1, 2018:
Question - "Are you guys thinking about moving up to the NASDAQ?"
CEO, Shital Mars: "Yes. So the ultimate goal has always been to become fully SEC reporting and list on NASDAQ. We think that is the right place and right path for us to go. And we think healthcare is ripe for that change and we think there’s a lot of competition and opportunity in the marketplace for a company like ours to create something special and unique and worthy of being on NASDAQ. We also know that we want to have the right vehicle for it. So it’s not something we want to do just as we are today. We want to evolve into that NASDAQ worthy company, and we are putting all the staff in place, all the factors, all the personnel and resources in place right now to get us to there as our end goal."
Entry into CBD/Hemp Market
Acquiring additional 12 out-of-state licenses, which will make them obtain a total 29 state licenses in the U.S. by EOY.
The following are our strategic goals for 2018:
Achieve 25,000 prescriptions filled in a single month by December 2018
Increase annual overall sales to $22 million
Secure additional 340B contracts and long term care facility relationships
Further expansion into Palm Beach County
Achieve accreditation for non-sterile compounding
Achieve full enterprise profitability and earnings growth
Publish 2nd year of audited financial statements and leverage these statements to secure new investment opportunities for mergers and acquisitions
Opening more Pharmco Pharmacy Resource Centers in retirement and long term care communities.
Strengthening our tele-pharmacy platform
Closing Remarks
The strength of Progressive Care has always been in the hands of its employees and its shareholders. Without the loyalty and dedication of both, this Company would not be where it is today. We have thrived because of the unyielding support in the face of immense challenges and we know that we must never waver in our desire to always earn the trust that has been bestowed upon us. Thank you to all who believe in us and we look forward to delivering another phenomenal year.
Just for your fun reading, I have compiled a short version of Progressive's long history since its inception in 2006 and even before that all the way to 1997. This company is indeed a GEM that has just been noticed by BIG money. Get in now and we will witness how this stock will make its way all the way to NASDAQ.
A short version of ProgressiveCare's long history:
Everything started from a person called Buddy Young. He founded a publicly traded company called Web Star Training in 1997, engaging in the development, production, and distribution of training and educational video products and services. The company then changed its name to Advanced Knowledge, Inc. in 2000; and to Advanced Media, Inc. in 2003. Later, the company changed its name to Advanced Media Training, Inc. in 2004. Advanced Media Training is based in Encino, California. As of December 11, 2006, Advanced Media Training, Inc. was acquired by Dematco Corporation, a private UK company, in a reverse merger.
Progressive Training Inc. was incorporated by Mr. Young in Delaware on October 31, 2006. From the date it was incorporated until March 1, 2007, it was a wholly owned subsidiary of Dematco, Inc. On March 1, 2007, to facilitate Dematco's exit from the training business, Progressive Training acquired all of Dematco's assets and liabilities related to the production and distribution of workforce training videos.
In 2006, another person, Avraham A. Friedman, together with two partners, founded Pharmco in Florida. Mr. Friedman started in 1996 at the clerk level and after 4 years in 2000 became retail manager for a busy New York City independent pharmacy. He then left New York for Florida and started Pharmco in 2006.
Then, on October 21, 2010, Progressive Training, Inc. entered into an Agreement and Plan of Reverse Merger with Pharmco Corp. Upon the closing of the Exchange, Buddy Young resigned as the Company’s sole officer and director and David Leedy, Dennis Spiegelman and Mel Powell resigned from their positions as members of the Company’s board of directors. Simultaneously with the effectiveness of the Merger a new board of directors and new officers were appointed. The new board of directors consists of Avraham A. Friedman, Andy Subachan and Alan Jay Weisberg. Avraham A. Friedman was appointed as the Company’s Chief Executive Officer and President. Andy Subachan was appointed as the Company’s Chief Operating Officer. Alan Jay Weisberg was appointed as our Chief Financial Officer.
Mr. Weisberg is a Certified Public Accountant and currently operates Weisberg Brause & Co. Mr. Weisberg served as chief financial officer and as a director of QuickByte Software, Inc., from July 2008 to July 14, 2009. He served as chief financial officer and as a director of Getting Ready Corporation, Inc. from September 2007 through September 2008. From April 1998 through December 2006, Mr. Weisberg served as chief financial officer and as a director of Orthodontix, Inc. In addition, Mr. Weisberg served as chief financial officer and as a director of Protalix Biotehrapeutics, Inc. from December 2006 through April 2007. Mr. Weisberg also serves as a member of the board of directors and as secretary of Protech Global Holdings Corp. (“Protech”) Mr. Weisberg also previously served as chief financial officer of Protech.
On November 24, 2010, Progressive Training, Inc. (the “Company”) filed a Certificate of Ownership and Merger, pursuant to which its wholly-owned subsidiary, Progressive Care Inc. was merged into and with the Company (the “Merger”). In connection with the Merger, the Company changed its name to “Progressive Care Inc.”
Effective January 1, 2011, Mr. Young's another company, Futura Pictures, Inc. acquired from Progressive Training, Inc. all of its assets and liabilities related to Progressive’s workforce training business. On February 27, 2015, Mr. Young sold Futura Pictures to some South Korean guys and the company's name was changed to IMK Group, Inc.
On March 23, 2012, Progressive's CEO Avraham Friedman, issued his inaugural annual letter to the shareholders. The letter outlined Progressive Care's accomplishments in 2011 as well as its strategic goals and initiatives for 2012. Some highlights included hiring world renowned recording artist Luther Campbell as a company spokesperson. Mr. Campbell is deeply involved in the company's community outreach program and in the development of our anti-retroviral patient management program. Mr. Campbell's work will also be in combination with the new initiative planned by Progressive Care and PharmCo's HIV/AIDS Action Committee headed by Mrs. McDonald, a former Florida Department of Health Program Manager. They also have begun delivering with their fleet of visually branded delivery vehicles delivering to all of South Florida. The fleet is part of a marketing effort to enhance visibility of PharmCo in South Florida. They also signed an LOI to acquire an independent pharmacy in Coral Springs, FL.
On April 30, 2012, Progressive Care entered into the Equity Agreement with TCA. TCA committed to purchase up to $2,000,000 of the Company’s common stock for a period of twenty-four (24) months.
On August 30, 2012, Progressive Care announced that it has hired Mr. Vernon Watson as Chief Executive Officer and Ms. Shital Parikh Mars as Chief Operating Officer, effective August 27, 2012. Ms. Parikh was also appointed to the Board of Directors of Progressive Care at meeting held on August 24, 2012. Mr. Avraham Friedman, the Company’s former CEO, remained Chairman of the Board and assumed the role as the Company’s Chief Compliance Officer.
Mr. Watson was a Regional Sales Manager for MOMS Pharmacy in Melville, New York before joining Progressive. He helped increase the company’s sales and market share from New York to the tri-state area and Florida.
Ms. Parikh has been a vital consultant to the Company for the past three years (2009 - 2012). As President and CEO of Spark Financial Consulting, Ms. Parikh provided business development consulting services in which she advised the Company on human resources, financial reporting and transactions, operations, compliance, SEC filings, and investor relations, among other things. Ms. Parikh was also the Chief Operating Officer of Basis Financial, a boutique investment banking firm engaged by the Company. Her experience in the financial services industry centers on operational management, preparation and submission of financial statements, mergers & acquisitions, securities offerings, SEC reporting, due diligence, compliance, and regulatory audits. Ms. Parikh currently maintains 8 securities license registrations including the Series 7, Series 66, and Series 24.
On, January 17, 2013, Mr. Vernon Watson resigned from his position as the Chief Executive Officer of Progressive Care, Inc. after only five months with the company. His own words in the resignation letter: "Please accept this letter as my two-week notice of resignation. My last day of work will be Jan 25 th , 2013. It's been a wonderful 5 month experience working with Progressive Care. I have decided to relocate back to New York. I have enjoyed working with each and every one of you and appreciate the opportunities I've been given. I will do my best to hand off any current appointments prior to my last day of work. Please let me know if you need my help in any other way."
On January 21, 2013, Mr. Avraham Friedman resigned from his position as Chairman of the Board of Directors (the “Board”) of the Company. His own words in the resignation letter: "I thank each and every one of you for the opportunity to sit as Chairman of the Board. Regrettably, I must resign my position as Chairman of the Board effective immediately. I will, however, continue to retain my position as Chief Compliance Officer and look forward to working together to improve and grow Progressive Care. I thank you."
On January 22, 2013, the Board approved by unanimous written consent the appointment of Mr. Alan Jay Weisberg as the Company’s Interim Chief Executive Officer and Chairman of the Board. Mr. Weisberg has been a member of the Board and has served as Chief Financial Officer of the Company since October 2010.
On February 5, 2013, Mr. Avraham Friedman resigned from his position as Chief Compliance Officer of Progressive Care Inc. (the “Company”). In connection with Mr. Friedman’s resignation, the Company provided severance payment in the form of one half of Mr. Friedman’s current salary and one half of the premiums for Mr. Friedman’s insurance policy for a period of twenty-four weeks. His resignation letter:"This letter shall serve as notice that effective immediately, I hereby resign from my position as Chief Compliance Officer with Progressive Care, Inc. (the "Company", and all other positions to which I have been assigned, regardless of whether I served in such capacity, of the Company. The resignation is not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices. Sincerely."
On May 17, 2013, the board of directors of Progressive Care, Inc. dismissed Berman & Co., P.A., as the Company’s independent registered public accounting firm. On the same day, the board approved the engagement of Mallah Furman, Certified Public Accountants (“Mallah”), as the Company’s new independent registered public accounting firm.
On September 3, 2014, the Circuit Court of the Second Judicial Circuit for Leon County, Florida approved the 3(a)(10) transaction between Progressive Care and Tarpon Bay Partners. Progressive and Tarpon reasonably estimated that the fair market value of the Settlement Shares, the Fee Shares (as defined below) and all other amounts received or to be received by Tarpon is equal to approximately $2,434,673.00.
On March 18, 2015, Progressive terminated 12g with SEC.
On Dec 29, 2014, COO, Shital Mars released an open letter to Shareholders. Highlights of 2014:
Agreement and court approval to execute a 3(a)(10) transaction through Tarpon Bay Partners, LLC to eliminate $1.8 million in debt in the coming year
Filed unaudited financial statements with OTCMarkets through the most recent completed quarter
Restructured Management
Aggressively cut costs
Began a hiring program to recruit talent and meet growing demand
Renovated our PhamCo facility
Increased filled prescription counts by approx. 50% from 8,500 scripts per month to almost 13,000
Increased pharmacy sales by 35% to $8.1 million through September 30, 2014
The strategic goals for 2015:
Increase filled prescription counts to 20,000 per month by December 2015
Increase annual overall sales to $15 million
Achieve full enterprise profitability
Eliminate approximately $1.8 million in debt from the balance sheet
Merge, acquire or otherwise align ourselves with a synergistic independent pharmacy to create economies of scale
On November 10, 2015, Progressive announced the fourth consecutive quarters of profitability for PharmCo, LLC. Through the first nine months of 2015, PharmCo, LLC has recorded nearly $350,000 in net income. This is a significant turnaround when compared to net losses of $114,000 for PharmCo during the same time period in 2014. PharmCo has recorded profits in every quarter for the past 12 months. Profitability and positive cash flow in PharmCo has been achieved through concentrated marketing efforts, expansion of the compounded medication department and month over month of net increases in prescription sales. Progressive Care's consolidated income was nearly break even in the third quarter when adjusted for stock based compensation of $147,000.
Due to dramatic increases in demand, PharmCo initiated plans to expand the pharmacy this quarter. The facility currently fills approximately 50,000 prescriptions per quarter with minimal square footage devoted to compounding and long term care operations. The expansion plan would nearly double the amount of general filling space plus expand the compounding department. The company also is in the process of choosing and purchasing a robotic dispensing system. This system will allow PharmCo to tremendously increase production and save on labor cost. To take advantage of its marketing capabilities the company plans to expand to Palm Beach County. PharmCo expects the expansion to produce numerous positive results including improvements to efficiency and capacity as well as increased revenues.
Recently, PharmCo began the process of establishing 340B sales. Both PharmCo and its 340B provider are installing the vendor data necessary to start purchasing inventory for 340B patients. The Company anticipates that we will be realizing sales in this area before the end of the year. PharmCo is also quickly increasing its footprint in the Medication Therapy Management (MTM) industry. On a monthly basis, the company is seeing increases in the number of MTM cases provided by Medicare plans. While the company does not expect a material impact on this year's sales from MTM cases, MTM will be an important part of the business in 2016.
On December 10, 2015, Progressive announced that it has completed its 3(a)(10) transaction. In total the company has issued 282,275,000 shares of common stock to eliminate over $1.9 million in aged debt off of its balance sheet. The company estimates that of these shares approximately 12,000,000 shares will be returned to treasury.
As of December 9, 2015, total common stock issued and outstanding was 352,043,045 shares. This number is net of a 1,718,000 share adjustment as these shares are beneficially owned by the company through PharmCo, LLC. The total number of shares that are not beneficially owned by insiders or affiliates was 306,833,938.
On Dec 14, 2015, Progressive announced record November pharmacy revenues. The pharmacy filled approximately 15,000 prescriptions during the month of November, which is nearly a 30% increase over the same month last year. Historically, due to the open enrollment window, physicians undergo major changes to their patient base resulting decreases in prescriptions written. However, PharmCo grossed approximately $1.3 million in net revenues for the month despite the lower prescription count. The compounding department continues to drive strong revenue growth.
In the week of Jan. 4, 2016, Progressive will issue 2016 Open Letter to shareholders.
In October, 2017, Progressive uplisted to OTCQB.
In Jan 2018, Progressive announced over $20M NET REVENUE for 2017.
In Feb 2018, Progressive announced all-time-high single month revenue of $2.25M and 23,000 prescription fills.
To be continued...
$$$RXMD
Yep... & OTTV's time will come within the next 2 - 4 weeks.
Mark it...
OTTV- TIME WILL SHOW US THE TRUTH!!!....
I believe that Management is not sitting behind a desk looking at the computer.....They are Working putting money time and effort to SUCCEED!!!......
<< We are working on being the best household name. Even the networks like the name Viva. Ty. Have a great weekend. Back to work.>>
Close to 2k
— Vivalive TV Official (@vivaentgroup) February 23, 2018
President Kennedy was One Guy...
Martin Luther King, Jr. was One Guy...
Albert Einstein was One Guy...
Mahatma Gandhi was One Guy...
William Shakespeare was One Guy...
Christopher Columbus was One Guy...
& Jesus Christ was One Guy...
I'm not saying Tom is any of these guys...
I'm saying YES... One Guy can change the world...
I will not be surprised if Tom turns out to be One of these Guys my friend...
Detractors calling for sub 15 to zero this past week but...
BVTK closed up 11+% green...
Next week will be even bettah...
We shall see...
Yep...
Put your ear muffs on and watch us close green... again...
Awesome for ONCI..!
New Tweet
just signed a huge distribution deal with a large middle America auto parts dealer contracts at lawyers will post when i get them back.
Revenue Rules for $ONCI
added another 12 sales people to our current roster
Its all falling into place
just wait and see...
Yep...
Put your ear muffs on and watch us close green... again...
$4.7M - $6.1M is just for the telecom business alone. A very small portion of what is going on here...Just one of many relationships.
https://investorshub.advfn.com/uimage/uploads/2018/2/7/osyfm4B8BE46F-9528-4947-B21F-682295AA08EE.png
Awesome for ONCI..!
New Tweet
just signed a huge distribution deal with a large middle America auto parts dealer contracts at lawyers will post when i get them back.
Revenue Rules for $ONCI
added another 12 sales people to our current roster
Its all falling into place
just wait and see...
Thank you kindly my friend...
Bravatek updates Shareholders on its Strategic Activities that are enabling more rapid Revenue Generation
Bravatek's strategic focus is generating revenue now with anticipated accelerated rates for remainder of 2018
Austin, TX -- February 22, 2018 -- InvestorsHub NewsWire -- Bravatek Solutions, Inc. (USOTCPink: BVTK, "Bravatek," or the "Company") communicates with shareholders, in an open and forthright way, to address its revenues, anticipated acceleration of revenues through its acquisitions, strategic agreements and joint ventures, as well as its plans for an optimal share structure.
Many shareholders reach out on a regular basis to encourage us to continue with the genuine progress we have demonstrated in creating top-tier, patent-pending cybersecurity software products, tools, and systems (such as telecom tower services). Bravatek is indeed a security-platform company envied by others through our contract vehicles like the $20B SEWP contract vehicle and our anticipated inclusion, in short order, on the GSA IT Schedule 70.
We have identified multiple firms as ideal partners and even potential acquirers. We are, in fact, working with potential equity partners negotiating deals. The Company completed the acquisition of HelpComm, which is now presented with robust sales opportunities as well as strategic agreements and/or joint ventures with firms like DarkPulse Technologies that have enabled us to quickly provide a broad range of cybersecurity software for the enterprise, as well as consumer; tools for small, medium and large enterprises; and top-tier telecom construction and services coast-to-coast, as we just announced in a recent press release.
Dr. Thomas A. Cellucci, Bravatek's Chairman and CEO, commented: "Our Board set strategic goals for Bravatek to enhance revenue generation and accelerate growth. These strategies are working and should provide the quarter-over-quarter revenue increases our shareholders want. In addition, we are exploring several plans to significantly alterin a positive waythe share structure to optimize and sustain our share price."
It was recently announced that Bravatek is moving to a December 31st fiscal year, accepting recommendations from our accountants and lawyers to align our fiscal year with our subsidiary and competitors, and to reduce costs and make future potential acquisitions easier to account for.
Bravatek is providing the following guidance for 2018, as projected by management at this time (see Note 1) for the telecom portion of our business:
Estimated Revenue between $4.7M and $5.1M
Note 1: These projections are based on management's interpretation of current activities and potential future telecom projects, and they are speculative "forward-looking statements" as described below.
About Bravatek Solutions, Inc.
Bravatek Solutions, Inc. is a high technology security solutions portfolio provider that assists corporate entities, governments and individuals protect their organizations against both physical and cyber-attacks through its offering of the most technically-advanced, cost-effective and reliable software, tools and systems.
For more information, visit www.bravatek.com
Media contact:
Bravatek Solutions, Inc.
media@bravatek.com
1.866.490.8590
Anyone know when the "D" falls away..?
Alright there ten... I'll call it an educated guess then because everything you pointed out is based on projected revenue. We won't know real rev till perhaps March from helpcom and is it May for BVTK..?
Bravatek updates Shareholders on its Strategic Activities that are enabling more rapid Revenue Generation
Bravatek's strategic focus is generating revenue now with anticipated accelerated rates for remainder of 2018
Austin, TX -- February 22, 2018 -- InvestorsHub NewsWire -- Bravatek Solutions, Inc. (USOTCPink: BVTK, "Bravatek," or the "Company") communicates with shareholders, in an open and forthright way, to address its revenues, anticipated acceleration of revenues through its acquisitions, strategic agreements and joint ventures, as well as its plans for an optimal share structure.
Many shareholders reach out on a regular basis to encourage us to continue with the genuine progress we have demonstrated in creating top-tier, patent-pending cybersecurity software products, tools, and systems (such as telecom tower services). Bravatek is indeed a security-platform company envied by others through our contract vehicles like the $20B SEWP contract vehicle and our anticipated inclusion, in short order, on the GSA IT Schedule 70.
We have identified multiple firms as ideal partners and even potential acquirers. We are, in fact, working with potential equity partners negotiating deals. The Company completed the acquisition of HelpComm, which is now presented with robust sales opportunities as well as strategic agreements and/or joint ventures with firms like DarkPulse Technologies that have enabled us to quickly provide a broad range of cybersecurity software for the enterprise, as well as consumer; tools for small, medium and large enterprises; and top-tier telecom construction and services coast-to-coast, as we just announced in a recent press release.
Dr. Thomas A. Cellucci, Bravatek's Chairman and CEO, commented: "Our Board set strategic goals for Bravatek to enhance revenue generation and accelerate growth. These strategies are working and should provide the quarter-over-quarter revenue increases our shareholders want. In addition, we are exploring several plans to significantly alterin a positive waythe share structure to optimize and sustain our share price."
It was recently announced that Bravatek is moving to a December 31st fiscal year, accepting recommendations from our accountants and lawyers to align our fiscal year with our subsidiary and competitors, and to reduce costs and make future potential acquisitions easier to account for.
Bravatek is providing the following guidance for 2018, as projected by management at this time (see Note 1) for the telecom portion of our business:
Estimated Revenue between $4.7M and $5.1M
Note 1: These projections are based on management's interpretation of current activities and potential future telecom projects, and they are speculative "forward-looking statements" as described below.
About Bravatek Solutions, Inc.
Bravatek Solutions, Inc. is a high technology security solutions portfolio provider that assists corporate entities, governments and individuals protect their organizations against both physical and cyber-attacks through its offering of the most technically-advanced, cost-effective and reliable software, tools and systems.
For more information, visit www.bravatek.com
Media contact:
Bravatek Solutions, Inc.
media@bravatek.com
1.866.490.8590
Well... where you're wrong again is...
Stating the stock is dead...
Everyone here can see ONCI is alive and kicking and trading actively... right now...
Whoops... there goes credibility my friend...
Still just a guess on your part since we don't factually know what revs BVTK has at this point...
I think your guess is inaccurate...
Here's my Guess:
The $6 milly is just from telecom business. The $17 milly is from DarkPulse. Total BVTK revs for 2018 should exceed $25 milly conservatively...
GUESS again ten...
Here's my Guess:
The $6 milly is just from telecom business. The $17 milly is from DarkPulse. Total BVTK revs for 2018 should exceed $25 milly conservatively...
Yep...
And is spite of all the doom and gloomers...
We'll closed green... again... tomorrow...
$4.7M - $6.1M is just for the telecom business alone. A very small portion of what is going on here...Just one of many relationships.
https://investorshub.advfn.com/uimage/uploads/2018/2/7/osyfm4B8BE46F-9528-4947-B21F-682295AA08EE.png
Sounds like you've really changed your tune there mr golf...
$APHDD: Yup.... major runner here..... looking at $0.01
Could do it here...
In agreement with you mr. cash...
I believe we'll close this month at 28 -30 or above.
We shall see...
Yep...
Buying at the "Ask" from day to day...
GOTTA ASK YOUR SELF.. DONT YOU THINK THE LENDER LOOKED PRETTY HARD INTO WHETHER OTTV WAS A GOOD RISK OR NOT... I PROMISE YOU THEY WENT THRU OTTV BUSINESS PLAN WITH A FINE TOOTH COMB.
IM NOT HAPPY WITH PPS, HOWEVER IM SMART ENOUGH TO KNOW THAT MAKES IT TIME TO BUY MORE. BEEN BOTTOMED RIGHT HERE FOR MONTHS ON END.
I'M BETTING LENDER CHECKED OUT OTTV TOP TO BOTTOM PRIOR TO ALLOWING ACCESS TO THAT KIND OF MONEY!
IGNITION SHOWS CONFIDENCE ABOUT VIVA FUTURE....
Ignition is a venture capital firm dedicated to helping the best entrepreneurs seize opportunity. With over $2B under management, Ignition invests in emerging and future leaders in enterprise software.
Ignition brings together an unparalleled combination of domain focus, technical expertise, and global operational experience. Ignition's partners are proven business leaders who have built some of the world's most successful businesses of the last two decades, including Microsoft Windows and Office, McCaw Cellular Communications, AT&T Wireless and Starbucks.
Ignition helps entrepreneurs by turning their early idea into a business, to hiring the right team, providing the right industry and functional insight and connections, to growing the business strategically, globally, financially, to realizing the best ultimate outcome, Ignition is ready to go the distance.
https://www.crunchbase.com/organization/ignition-partners
Wonderful..!
I've got a Millie Buy Order in for BVTK then...
I appreciate your insights my friend...
New York, NY -- February 5, 2018 -- InvestorsHub NewsWire -- On4Communications (OTC:ONCI):
Financials
We had a stellar yr grossing over 1.8 million from nothing last yr
We were up 50 plus percent quarter over quarter and far out paced expectations.
In regards to the 2 million dollar payment that was to buy the remainder of FMS marketing that we did not own.
Alan Baily and I are in negotiations with the Del SOS to reduce the debt owed.
The debt is nowhere near $900 thousand that is a number that they put on all companies until they file. In regards to the share reduction I stated on page 2 that the reduction has been reported with the Colorado SOS and is under Hexagon Holdings. As soon as we get approval the share reduction will be in place. I have also reduced my commission rate to 12.5 percent a 50% reduction so we will have more cash for all the things we need to do.
Wrong...
Try giving a fictitious number to the IRS or your CPA and see what happens... $1.6 - $1.8 Mill on the books...